InvestorsHub Logo
Followers 1320
Posts 26903
Boards Moderated 6
Alias Born 12/10/2012

Re: None

Friday, 02/21/2020 1:19:47 PM

Friday, February 21, 2020 1:19:47 PM

Post# of 841
$AKAOQ: Yup.... Sihuan is working on nCovD19 colloboration



Hence the Achaogen interest.



Its all tying up.



https://www.thepharmaletter.com/in-brief/brief-china-s-sihuan-collaborates-with-hetero-drugs




GO $AKAOQ



****************************************************************

Hainan province, China-based Sihuan Pharmaceutical has signed an agreement with the Indian pharma company Hetero Drugs.

According to a statement, the two companies will work on R&D, regulatory affairs, manufacturing and commercialization in China.

The areas of focus for the collaboration include cardiovascular diseases, central nervous system diseases and infections such as the 2019-nCoV infection, which is spreading fast in China and has been seen elsewhere.

A major HIV and oncology drug supplier, Hetero is no stranger to China.

In 2014, it formed a joint venture with Henan province-based drug maker Furen Group to sell oncology drugs in China.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.